M, A., S, P., A, P., R, A., ML, C., DZ, C., . . . A, D. (2019). Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data. Diabetes care, 42(8), 1454. https://doi.org/10.2337/dc19-0342
Chicago Style (17th ed.) CitationM, Afkarian, et al. "Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data." Diabetes Care 42, no. 8 (2019): 1454. https://doi.org/10.2337/dc19-0342.
MLA (9th ed.) CitationM, Afkarian, et al. "Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data." Diabetes Care, vol. 42, no. 8, 2019, p. 1454, https://doi.org/10.2337/dc19-0342.